SGCA
LABP

Steel Grove Capital Advisors’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History

Steel Grove Capital Advisors’s Portfolio LABP Stock Details LABP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,000
Closed -$2.98K – 209
2023
Q1 		$2.98K Sell
1,000
-8,450
-89% -$25.2K ﹤0.01% 190
2022
Q4 		$47.3K Buy
9,450
+1,000
+12% +$5K 0.01% 178
2022
Q3 		$55K Buy
+8,450
New +$55K 0.01% 151